fluconazole has been researched along with Infection in 8 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Eligible participants presenting with an active vulvovaginal candidiasis infection entered an induction phase in which they were randomly assigned 2:1 to receive 600 mg oral oteseconazole on day 1 and 450 mg on day 2, with matching placebo capsules, or to 3 sequential 150-mg oral doses (once every 72 hours) of fluconazole, with matching placebo capsules." | 5.51 | Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections. ( Brand, SR; Curelop, S; Degenhardt, T; Flynt, A; Ghannoum, M; Martens, MG; Maximos, B; Person, K, 2022) |
| "Fluconazole (FLZ) is a new azole antifungal drug having no earlier record of its utilization for the treatment of fish diseases." | 3.85 | Effects of fluconazole based medicated feed on haemato-immunological responses and resistance of Labeo rohita against Saprolegnia parasitica. ( Goswami, P; Pal, AK; Saha, H; Saha, RK; Sahu, NP, 2017) |
| "Fluconazole appears to be an effective alternative to conventional drugs for the treatment of cutaneous protothecosis." | 1.29 | Successful treatment with fluconazole of protothecosis developing at the site of an intralesional corticosteroid injection. ( Chae, YS; Kim, ST; Kim, YJ; Suh, KS, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Martens, MG | 1 |
| Maximos, B | 1 |
| Degenhardt, T | 1 |
| Person, K | 1 |
| Curelop, S | 1 |
| Ghannoum, M | 1 |
| Flynt, A | 1 |
| Brand, SR | 1 |
| Saha, H | 1 |
| Pal, AK | 1 |
| Sahu, NP | 1 |
| Saha, RK | 1 |
| Goswami, P | 1 |
| Wang, F | 1 |
| Feng, P | 1 |
| Lin, Y | 1 |
| Chen, X | 1 |
| Xu, D | 1 |
| Wang, Z | 1 |
| Han, J | 1 |
| Fang, JL | 1 |
| Sorita, A | 1 |
| Carey, WA | 1 |
| Colby, CE | 1 |
| Murad, MH | 1 |
| Alahdab, F | 1 |
| Shaoxi, W | 1 |
| Guixia, L | 1 |
| Yongnian, S | 1 |
| Ningru, G | 1 |
| Kim, ST | 1 |
| Suh, KS | 1 |
| Chae, YS | 1 |
| Kim, YJ | 1 |
| Blaschke-Hellmessen, R | 1 |
| Gibb, AP | 1 |
| Aggarwal, R | 1 |
| Swainson, CP | 1 |
2 reviews available for fluconazole and Infection
| Article | Year |
|---|---|
Human Cutaneous Protothecosis: A Case Report and Review of Cases from Mainland China, Hong Kong, and Taiwan.
Topics: Aged; Anti-Infective Agents; China; Cluster Analysis; DNA, Plant; DNA, Ribosomal; Fluconazole; Genot | 2018 |
Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis.
Topics: Antifungal Agents; Erythrocyte Transfusion; Fluconazole; Humans; Infant, Newborn; Infant, Premature; | 2016 |
1 trial available for fluconazole and Infection
| Article | Year |
|---|---|
Phase 3 study evaluating the safety and efficacy of oteseconazole in the treatment of recurrent vulvovaginal candidiasis and acute vulvovaginal candidiasis infections.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Inf | 2022 |
5 other studies available for fluconazole and Infection
| Article | Year |
|---|---|
Effects of fluconazole based medicated feed on haemato-immunological responses and resistance of Labeo rohita against Saprolegnia parasitica.
Topics: Animal Feed; Animals; Antifungal Agents; Cyprinidae; Diet; Disease Resistance; Dose-Response Relatio | 2017 |
The first case of Protothecosis zopfii in China.
Topics: Adolescent; Antifungal Agents; Cheek; Epidermis; Female; Fluconazole; Humans; Infections; Prototheca | 2000 |
Successful treatment with fluconazole of protothecosis developing at the site of an intralesional corticosteroid injection.
Topics: Antifungal Agents; Female; Fluconazole; Humans; Infections; Middle Aged; Prototheca; Skin; Skin Dise | 1996 |
[Fluconazole and itraconazole susceptibility testing with clinical yeast isolates and algae of the genus Prototheca by means of the Etest].
Topics: Antifungal Agents; Candida; Candidiasis; Drug Evaluation, Preclinical; Fluconazole; Humans; Infectio | 1996 |
Successful treatment of Prototheca peritonitis complicating continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Diabetes Mellitus, Type 1; Fluconazole; Flucytosine; Humans; Infections; Male; Middl | 1991 |